Latest News

A Trial Talk mini-series will explore the trial’s journey from its inception in the early 2000s to the end of patient recruitment in March 2023.
SNIP-AFRICA, a new European-African collaboration to improve the way infections in newborn babies are treated, has launched.
Newer antiretroviral combinations including tenofovir alafenamide and dolutegravir are superior to older second-line options for children living with HIV, according to results from the CHAPAS-4 trial.
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutions will showcase their latest work on HIV trials at the 12th International AIDS Society (IAS) Conference on HIV Science.
In the latest Trial Tak episode, we explore the REFINE trial which tests whether giving immunotherapy less often can still treat cancer effectively, whilst improving quality of life for patients.